tirzepatide to ozempic conversion Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are What is the recommended conversion

The CMA count and the timing gap The CMA's consumer-facing explainer states that, as of late December 2025, Health Canada had nine active applications from companies that want to sell generic semaglutide

While most people will experience appetite suppression within a week of starting Zepbound, factors such as dosage, metabolism, and diet can all impact the effectiveness of the treatment

According to research in Diabetes Care, most side effects are mild to moderate and decrease over time

For example, since the 1940s, the field has been striving to develop an oral formulation of insulin, but still, no widely adopted oral formulation has been discovered

One criticism is that syringes are too big at 3ml and ga, should be insulin 100iu needles

The off-cycle is intended to keep the GH receptor responsive